Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase NA 5Phase 1 3Phase 3 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Recruiting 2Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Multiple Myeloma 25Breast Neoplasms 21Colorectal Neoplasms 17Neoplasms 16Prostatic Neoplasms 15Lymphoma, B-Cell 15Stomach Neoplasms 13Carcinoma, Hepatocellular 12Recurrence 11Pancreatic Neoplasms 11Lung Neoplasms 11Leukemia, Myeloid, Acute 11Carcinoma, Non-Small-Cell Lung 11Burkitt Lymphoma 11Solid Tumor 10Uterine Cervical Neoplasms 9Lymphoma, Non-Hodgkin 9Glioblastoma 9Leukemia 8Ovarian Neoplasms 7Glioma 7Sarcoma 6Polycystic Ovary Syndrome 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Large B-Cell, Diffuse 5Lymphoma 5Hematologic Neoplasms 5Head and Neck Neoplasms 5Neuroendocrine Tumors 4Lymphoma, T-Cell, Peripheral 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Digestive System Neoplasms × Clear all
NCT05287165 2022-03-18

Clinical Trial to Evaluate the Safety and Efficacy of IM96 CAR-T Cells Therapy in Patients With Advanced Digestive System Neoplasms

Beijing Immunochina Medical Science & Technology Co., Ltd.

Phase EARLY_PHASE1 Unknown
19 enrolled
Gastrointestinal

Colonic Neoplasms, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡